PDI Reducing Reliance On Top Pharma Clients

Contract sales organization’s top four clients – AstraZeneca, GSK, Novartis and Sanofi-Aventis – will represent 59% of 2005 revenue, versus 81% in 2004, PDI says. Contracts with three of the four companies have been renewed.